Amgen’s Phosphate Binder Loss May Be Genzyme’s Gain

Once expected to plunder Renagel market share, AMG 223 suddenly gets left on the shelf.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet